Neurology Alert – June 1, 2005
June 1, 2005
View Issues
-
Treating Intracerebral Hemorrhage: Where Does the Blade Fade Away and the Neuro-Intensivist Move In?
Surgical treatment was associated with a cost savings due to shorter hospital stays and the use of fewer services upon discharge into the community. -
Clopridogrel and Aspirin in Symptomatic Carotid Stenosis: The CARESS Trial
Clopidogrel and aspirin therapy is more effective than aspirin alone in reducing asymptotic MES in patients with recently symptomatic CS. -
Magnesium Sulfate is a Promising Neuroprotective Agent
The use of magnesium may reduce ischemic complications after SAH and thereby may reduce the risk of poor outcome after SAH, but as yet, the evidence for its use in clinical practice is inconclusive. -
Statins for the Treatment of Alzheimer’s Disease
Atorvastatin reduces cholesterol levels and improves cognition in Alzheimer’s disease patients. -
Antibody-Mediated Transfer of Paraneoplastic Stiff-Person Syndrome
Immunohistochemistry revealed perivascular staining in spinal cords for human IgG in rats that received high-titer antibodies, high doses of low-titer antibodies or high doses of control IgG. -
Whipple’s Disease
Progression of the cord lesion and lack of steroid response prompted antibiotic treatment for Whipple’s disease. -
Celiac Autonomic Neuropathy
Celiac disease is present in 2.4% of patients referred for suspected dysautonomia, similar to the 2.5% incidence of celiac disease in idiopathic peripheral neuropathy. -
Pharmacology Watch: Is Nesiritide Associated with a Higher Death Rate?
Nesiritide, Scios' intravenous recombinant form of human B-type naturetic peptide, has been widely used for the treatment of congestive heart failure in hospitalized patients. -
Clinical Briefs in Primary Care Supplement